SCA Pharmaceuticals has recalled 10 lots of compounded heparin sodium, an anticoagulant packaged in 500 mL or 1000 mL intravenous bags, the Food and Drug Administration announced yesterday. The bags contain the undeclared benzyl alcohol, a preservative that can cause serious adverse reactions in premature and low birth weight infants.

Related News Articles

Headline
Adults should be screened for colon cancer beginning at age 45 rather than 50, even in the absence of symptoms and personal or family history related to…
Headline
The AHA Oct. 21 at noon ET will host a webinar featuring leaders from Henry Ford Health System, Ascension Wisconsin and Loyola University Chicago’s Stritch…
Headline
Hospital and health system trustees are promoting value in their communities by tackling societal factors that influence the health and well-being of residents…
Headline
The Department of Health and Human Services and the Steven and Alexandra Cohen Foundation Oct. 10 announced the LymeX Innovation Accelerator, a $25 million,…
Headline
U.S. Surgeon General Jerome Adams, M.D., yesterday released a report urging Americans to recognize and address hypertension control as a national public health…
Headline
The AHA and Aligning for Health Sept. 24 hosted a webinar detailing how hospitals and health systems are working to better identify and address health, social…